Target type: molecularfunction
Binding to cyclosporin A, a cyclic undecapeptide that contains several N-methylated and unusual amino acids. [GOC:mb]
Cyclosporin A (CsA) is a potent immunosuppressant drug that binds to the immunophilin cyclophilin A (CypA) with high affinity. This interaction inhibits the activity of calcineurin, a phosphatase that plays a crucial role in T cell activation.
CsA-CypA complex binds to calcineurin, blocking its dephosphorylation activity. Calcineurin normally dephosphorylates the nuclear factor of activated T cells (NFAT), allowing it to translocate to the nucleus and initiate transcription of genes involved in T cell activation, including cytokine production.
By inhibiting calcineurin, CsA prevents NFAT activation and thereby suppresses T cell activation, proliferation, and cytokine production. This immunosuppressive effect is critical for preventing rejection of transplanted organs and autoimmune disorders.
The binding of CsA to CypA is a highly specific and selective process. CsA interacts with a hydrophobic pocket within CypA, forming a stable complex. This interaction is mediated by a combination of hydrogen bonds, van der Waals forces, and hydrophobic interactions.
The molecular mechanism of CsA binding to CypA and its subsequent inhibition of calcineurin is a complex interplay of protein-protein interactions and conformational changes. This intricate process highlights the importance of understanding the molecular basis of drug action for developing targeted therapies.
In summary, CsA binds to CypA, preventing its interaction with calcineurin. This inhibition of calcineurin activity leads to the suppression of T cell activation and subsequent immunosuppressive effects. The binding mechanism involves specific interactions within a hydrophobic pocket of CypA, highlighting the crucial role of molecular interactions in drug action.'
"
Protein | Definition | Taxonomy |
---|---|---|
Peptidyl-prolyl cis-trans isomerase D | A eukaryotic-type peptidyl-prolyl cis-trans isomerase D that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q08752] | Homo sapiens (human) |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | A protein phosphatase 3 catalytic subunit alpha that is encoded in the genome of human. [PRO:CNA, UniProtKB:Q08209] | Homo sapiens (human) |
Calcineurin subunit B type 1 | A calcineurin subunit B type 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P63098] | Homo sapiens (human) |
Peptidyl-prolyl cis-trans isomerase A | A peptidyl-prolyl cis-trans isomerase A that is encoded in the genome of human. [PRO:DNx, UniProtKB:P62937] | Homo sapiens (human) |
Peptidyl-prolyl cis-trans isomerase F, mitochondrial | A peptidyl-prolyl cis-trans isomerase F, mitochondrial that is encoded in the genome of human. [PRO:DNx, UniProtKB:P30405] | Homo sapiens (human) |
Peptidyl-prolyl cis-trans isomerase B | A eukaryotic peptidyl-prolyl cis-trans isomerase B that is encoded in the genome of human. [PRO:DNx, UniProtKB:P23284] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
2,4-pyridinedicarboxylic acid | lutidinic acid : A pyridinedicarboxylic acid carrying carboxy groups at positions 2 and 4. | pyridinedicarboxylic acid | |
daminozide | daminozide: induces tumors | straight-chain fatty acid | |
prolinal | pyrrolidines | ||
tacrolimus | tacrolimus (anhydrous) : A macrolide lactam containing a 23-membered lactone ring, originally isolated from the fermentation broth of a Japanese soil sample that contained the bacteria Streptomyces tsukubaensis. Tacrolimus: A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro. | macrolide lactam | bacterial metabolite; immunosuppressive agent |
tamoxifen | stilbenoid; tertiary amino compound | angiogenesis inhibitor; antineoplastic agent; bone density conservation agent; EC 1.2.3.1 (aldehyde oxidase) inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; estrogen antagonist; estrogen receptor antagonist; estrogen receptor modulator | |
oxalylglycine | N-oxalylglycine : An amino dicarboxylic acid that is iminodiacetic acid with an oxo substituent. It is used as an inhibitor of alpha-ketoglutarate dependent (EC 1.14.11.*) enzymes. oxalylglycine: structure given in first source | amino dicarboxylic acid; N-acylglycine | EC 1.14.11.* (oxidoreductase acting on paired donors, 2-oxoglutarate as one donor, incorporating 1 atom each of oxygen into both donors) inhibitor |
cyclosporine | ramihyphin A: one of the metabolites produced by Fusarium sp. S-435; RN given refers to cpd with unknown MF | homodetic cyclic peptide | anti-asthmatic drug; anticoronaviral agent; antifungal agent; antirheumatic drug; carcinogenic agent; dermatologic drug; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; geroprotector; immunosuppressive agent; metabolite |
sanglifehrin a | sanglifehrin A: binds cyclophilin A; isolated from Streptomyces; structure in first source | ||
(melle-4)cyclosporin | (melle-4)cyclosporin: a non-immunosuppressive analog of cyclosporin A | ||
cyclosporin g | cyclosporin G: similar immunosuppressive actions as cyclosporin, but without nephrotoxic side effects; cyclosporin A analog; MW 1217 | ||
scy-635 | |||
nutlin-3a | nutlin 3: an MDM2 antagonist; structure in first source | stilbenoid | |
alisporivir | alisporivir: nonimmunosuppressive cyclosporin analog; structure/sequence in first source | homodetic cyclic peptide | anticoronaviral agent |